PIERS and BIS, sFIT:PIGF, Adrenomedullin
Recruiting · NCT02578810 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
Pre-eclampsia, more than being proteinuric gestational hypertension alone, is a state of exaggerated systemic inflammation and remains a leading direct cause of maternal morbidity and mortality worldwide.1 Standardization of antenatal and postnatal assessment and surveillance of pre-eclampsia with protocols that recognize the systemic inflammatory model of preeclampsia have been associated with reduced maternal morbidity.
Who can take part
Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Pregnancy at any stage (3 trimesters)
- Eclampsia (Frank eclampsia) will be the crux of the study
- Pre-eclampsia that is suspected will end up with Frank Eclampsia
Exclusion criteria
- Any neurological conditions that can alter the electroencephalography like epilepsy
- Any medical conditions that can alter the electroencephalography like hypoglycemia
Where it is running
1 location listed.
- Medical Ethics Committee, University Malaya Medical Centre - Kuala Lumpur, Malaysia